Keywords
mycotoxin
interleukin 6
mice
liver
Abstract
Patulin is a mycotoxin produced by many species of the fungi. The toxic action of patulin mainly affects the gastrointestinal tract and the immune system. The aim of our work was to assess the toxic effect of patulin, based on the analysis of interleukin IL-6 concentrations in the liver of test animals loaded with different doses of this mycotoxin. The research was conducted on mice which were assigned to 6 groups receiving different doses of active substances. After decapitation, their livers were taken for laboratory testing.
Our studies have shown that chronic intoxication with patulin at 0.1 LD50 leads to a statistically significant increase in IL-6 concentration in the liver of the animals. We also found that the loading of experimental animals with a single dose of patulin in the amount of 0.5 LD50 and 0.2 LD50 also leads to a statistically significant increase in this interleukin in the examined organ. There was no difference in its concentration compared to the control group only after the single dose of the lowest concentration of patulin, while the highest average IL-6 concentration was recorded in the liver of animals loaded with the highest single dose of patulin. After applying, one-time doses of this mycotoxin in the amount of 0.2 LD50 and 0.1 LD50, the mean concentrations of IL-6 in the liver in animals from these groups were statistically significantly lower.In conclusion, the analysis of the obtained results confirms the fact of the hepatotoxic effect of patulin.
References
1. Puel O, Galtier P, Oswald IP. Biosynthesis and Toxicological Effects of Patulin. Toxins. 2010;2(4):613-31.
2. Bennet JW, Klich M. Mycotoxins. Clin Microbiol Rev. 2003;16(3):497-516.
3. Chełkowski J. Mikotoksyny, grzyby toksynotwórcze i mikotoksykozy. http://www.cropnet.pl/dbases/mycotoxins.pdf.pl/download. 2010, [accessed 2010 June 20].
4. Wilson DM, Mubatanhema W, Jurjevic Z. Biology and ecology of mycotoxigenic Aspergillus species as related to economic and health concerns. Adv Exp Med Biol. 2002;504:1-17.
5. Balas J. Mikotoksyny jako źródło zanieczyszczeń żywności pochodzenia roślinnego. Postępy Fitoterapii. 2006;2:98-104.
6. Grajewski J. Mikotoksyny i grzyby pleśniowe. Zagrożenie dla człowieka i zwierząt. Bydgoszcz. Wyd. UKW, 2006.
7. Jarzynka S, Dąbkowska M, Netsvyetayeva I, Swoboda-Kopeć E. Mikotoksyny – niebezpieczne metabolity grzybów pleśniowych. Medycyna Rodzinna. 2010;4:113-9.
8. Santini A, Raiola A, Meca G, Ritieni A. Aflatoxins, Ochratoxins, Trichotecenes, Patulin, Fumonisins and Beauvericin in Finished Products for Human Consumption. J Clin Toxicol. 2015;5(4):2-11.
9. Szymczyk K, Szteke B, Goszcz H. Występowanie patuliny w krajowych sokach jabłkowych. Roczn PZH. 2004;55(3):255-60.
10. Kurpińska-Jaworska J, Ledzion E, Szczęsna M, Karłowski K, Postupolski J, Rybińska K. Nowe przepisy Unii Europejskiej w zakresie patuliny. Roczn PZH. 2003;54(4): 355-61.
11. Rozporządzenie Komisji Wspólnoty Europejskiej NR 1881/2006 z dnia 19 grudnia 2006 r. ustalające najwyższe dopuszczalne poziomy niektórych zanieczyszczeń w środkach spożywczych. L364 5-24.
12. Wróbel B. Zagrożenia zwierząt i ludzi toksynami grzybów pleśniowych zawartych w paszach i żywności. Woda-Środowisko- Obszary Wiejskie. 2014;14:159-76.
13. Al-Hazmi MA. Patulin in apple juice and its risk assessments on albino mice. Toxicol Ind Health. 2014;30(6):534-45.
14. Arzu Koçkaya E, Selmanoğlu G, Ozsoy N, Gül N. Evaluation of patulin toxicity in the thymus of growing male rats. Arh Hig Rada Toksikol. 2009;60:411-8.
15. Bouhet S, Oswald IP. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet Immunol Immunopathol. 2005;108:199-209.
16. Glaser N, Stopper H. Patulin: Mechanism of genotoxicity. Food Chem Toxicol. 2012;50(5):1796-801.
17. Grajewski J, Twarużek M. Zdrowotne aspekty oddziaływania grzybów pleśniowych i mikotoksyn. Alergia. 2004;3:45-9.
18. Ozsoy N, Selmanoğlu G, Koçkaya EA, Gül N, Cebesoy S. Effect of patulin on the interdigitating dendritic cells (IDCs) of rat thymus. Cell Biochem Funct. 2008;26(2):192-6.
19. Pfeiffer E, Diwald TT, Metzler M. Patulin reduces glutathione level and enzyme activities in rat liver slices. Mol Nutr Food Res. 2005;49(4):329-36.
20. Roll R, Matthiaschk G, Korte A. Embryotoxicity and mutagenicity of mycotoxins. J Environ Pathol Toxicol Oncol. 1990;10:1-7.
21. Mahfoud R, Maresca M, Garmy N, Fantini J. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicol Appl Pharmacol. 2002;15,181(3):209-18.
22. Maresca M, Yahi N, Younès-Sakr L, Boyron M, Caporiccio B, Fantini J. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: Stimulation of interleukin-8 secretion, potentiation of interleukin- 1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol Appl Pharmacol. 2008;228:84-92.
23. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg. 1997;206:30-9.
24. Nagwa M, El-Sawi NM, Gashlan HM, Younes SH, Al-Massabi RF, Shaker S. Biochemical and histological studies on the effect of the Patulin mycotoxin on male rats’ liver and treatment by crude venom extracted from jelly fish. Life Sci J. 2012;9(4):1143-53.
25. Song E, Xia X, Su C, Dong W, Xian Y, Wang W, et al. Hepatotoxicity and genotoxicity of patulin in mice, and its modulation by green tea polyphenols administration. Food Chem Toxicol. 2014;71:122-7.
26. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006;63:321-9.
27. Wichmann G, Herbarth O, Lehmann I. The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells. Environ Toxicol. 2002;17:211-8.
28. Seidelin JB, Bjerrum JT, Coskun M, Widjaya B, Vainer B, Nielsen OH. IL-33 is upregulated in colonocytes of ulcerative colitis. Immunol. Lett. 2010;128:80-5.
29. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 2006:8(2):2-8.
30. Gaini S, Koldkjaer OG, Pedersen C. Procalcitonin, lipopoly-saccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care. 2006:10:53.
31. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13:357-68.
32. Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol. 2010;22(5):347-52.
33. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006;63:321-9.
34. Bondy GS, Pestka JJ. Immunomodulation by fungal toxins. J Toxicol Environ Health. 2000;3(2):109-43.
35. Dziennik Urzędowy Unii Europejskiej. L50/8 z 27.02.2010.
36. Gashlan HM. Biochemical Studies of Patulin on Liver Functions in Male Albino Mice. J Apple Anim Res. 2008;34(1):93-6.
37. Walusia J, Gutarowska B, Żakowska Z, Pałczyński C. Grzyby Pleśniowe w środowisku komunalnym i w miejscu pracy – istotne zagrożenie zdrowotne. Medycyna Pracy. 2004;55(3):257-66.
38. Luft P, Oostingh GJ, Gruijthuijsen Y, Horejs-HoeckJ, Lehmann I, Duschl A. Patulin Influences the Expression of Th1/Th2 Cytokines by Activated Peripheral Blood Mononuclear Cells and T Cells Through Depletion of Intracellular Glutathione. Environ Toxicol. 2008;23:84-95.
39. Puel O, Tadrist S, Delaforge M, Oswald IP, Lebrihi A. The inability of Byssochlamys fulva to produce patulin is related to absence of 6-methylsalicylic acid synthase and isoepoxydon dehydrogenase genes. Int J Food Microbiol. 2007;115:131-9.
40. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 2006;8(2):2-8.
41. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13:357-68.
42. Urbanowicz W. Rola wątroby w odpowiedzi ostrej fazy. Postępy Nauk Medycznych. 2000;1:46-9.
43. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 2004;113:1251-3.
44. Koczy-Baron E, Kasperska-Zając A. Rola naczyniowo-śródbłonko-wego czynnika wzrostu w procesach zapalnych. Postępy Hig Med Dośw. 2014;68:57-65.
45. Zhang Y, Matsuo H, Morita E. Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis. Arch Dermatol Res. 2006;297:425-9.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2019 Autors